| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.3 |